CIK 0001357459
- Non-accelerated filer
- Smaller reporting company
PALISADE BIO, INC.
Sign in to watch- Ticker
- PALI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 522007292
- Phone
- +1 858-704-4900
- Business address
- 7750 EL CAMINO REAL, SUITE 5200, CARLSBAD, CA, 92009
- Former names
- PALISADE BIO, INC., Seneca Biopharma, Inc., Neuralstem, Inc.
- 4 Open-market buy Chief Executive Officer bought 35,715 shares at $0.28 ($10,000)
- 4 Open-market buy Chief Executive Officer bought 35,715 shares at $0.28 ($10,000)
- 4 Open-market buy Chief Financial Officer bought 31,250 shares at $0.32 ($10,000)
- 4 Open-market buy Chief Executive Officer bought 31,250 shares at $0.32 ($10,000)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes CEO gave up 6,465 shares (to pay taxes)
- 4 Option exercise Director acquired 15,000 shares (option exercise)
- 4 Shares withheld for taxes CEO gave up 37,776 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 39,178 shares (to pay taxes)
- 4 Open-market sale Chief Scientific Officer sold 25,000 shares at $1.09 ($27,250)
- 4 Open-market sale Chief Scientific Officer sold 25,000 shares at $1.18 ($29,500)
- 4 Open-market sale Chief Scientific Officer sold 25,000 shares at $1.17 ($29,355)
- 4 Gift CEO gave 66,953 shares (gift)
- 4 Open-market sale Chief Scientific Officer sold 25,000 shares at $1.13 ($28,190)
- 4 Open-market sale Chief Scientific Officer sold 25,000 shares at $1.23 ($30,690)
- 4 Open-market sale Chief Scientific Officer sold 25,000 shares at $1.31 ($32,725)
- 4 Open-market sale Chief Scientific Officer sold 25,000 shares at $1.26 ($31,460)
- 4 Open-market sale Chief Scientific Officer sold 25,000 shares at $1.64 ($41,000)
- 4 Gift CEO gave 100,000 shares (gift)
Page 10 of 18 · 343 filings